These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24267055)

  • 21. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K; Iseki E; Uchiyama H; Watanabe Y; Haga T; Kameyama K; Ikeda T; Yamamoto T; Kosaka K
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):209-13. PubMed ID: 10406992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise protects synaptic density in a rat model of Parkinson's disease.
    Binda KH; Lillethorup TP; Real CC; Bærentzen SL; Nielsen MN; Orlowski D; Brooks DJ; Chacur M; Landau AM
    Exp Neurol; 2021 Aug; 342():113741. PubMed ID: 33965411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of brain muscarinic acetylcholinergic receptors in living mice using a simple probe, [125I]-4-iododexetimide and [125I]-4-iodolevetimide.
    Sasaki M; Müller-Gärtner HW; Lever JR; Ravert HT; Dannals RF; Guilarte TR; Wagner HN
    Neuropharmacology; 1993 Dec; 32(12):1441-3. PubMed ID: 8152535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of
    Lepelletier FX; Vandesquille M; Asselin MC; Prenant C; Robinson AC; Mann DMA; Green M; Barnett E; Banister SD; Mottinelli M; Mesangeau C; McCurdy CR; Fricke IB; Jacobs AH; Kassiou M; Boutin H
    Theranostics; 2020; 10(18):7938-7955. PubMed ID: 32724451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
    Colloby SJ; McKeith IG; Wyper DJ; O'Brien JT; Taylor JP
    J Neurol; 2015 Sep; 262(9):2144-53. PubMed ID: 26122542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain.
    Piggott M; Owens J; O'Brien J; Paling S; Wyper D; Fenwick J; Johnson M; Perry R; Perry E
    J Chem Neuroanat; 2002 Sep; 24(3):211-23. PubMed ID: 12297267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of myocardial muscarinic receptors in streptozotocin-induced diabetic rats using iodine-123 N-methyl-4-iododexetimide.
    Mardon K; Kassiou M; Katsifis A; Najdovski L
    Eur J Nucl Med; 1999 Jul; 26(7):743-9. PubMed ID: 10398822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
    Shiozaki K; Iseki E
    J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
    Brown D; Chisholm JA; Owens J; Pimlott S; Patterson J; Wyper D
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):296-300. PubMed ID: 12552349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra.
    Löschmann PA; De Groote C; Albrecht C; Darstein M; Deransart C; Landwehrmeyer GB; Lücking CH; Feuerstein TJ
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):414-21. PubMed ID: 11330335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.
    Duda JE
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():3-14. PubMed ID: 14676464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.
    Dupont S; Semah F; Loc'h C; Strijckmans V; Baulac M; Samson Y; Mazière B
    J Nucl Med; 1999 Jun; 40(6):935-41. PubMed ID: 10452308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.
    Muma NA; Lee JM; Gorman L; Heidenreich BA; Mitrovic I; Napier TC
    Exp Neurol; 2001 Mar; 168(1):135-43. PubMed ID: 11170728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic approaches to cholinergic deficiency in Lewy body diseases.
    Barrett MJ; Cloud LJ; Shah H; Holloway KL
    Expert Rev Neurother; 2020 Jan; 20(1):41-53. PubMed ID: 31577469
    [No Abstract]   [Full Text] [Related]  

  • 40. Receptor function in cortical rat brain regions after lesion of nucleus basalis.
    Schliebs R; Feist T; Rossner S; Bigl V
    J Neural Transm Suppl; 1994; 44():195-208. PubMed ID: 7897391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.